Accessibility Menu
Beamtree logo

Beamtree(ASX) BMT

Market CapA$32.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-39%
5 Year-77%
1 Year-56%
1 Month-8%
A$0.11
+0.00%
+0.00Today
Beamtree last closing stock price
MetricPriceDate
Last closeAUD 0.112026-08-14
Beamtree stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-8.33%AUD 0.122026-08-07
1 month-8.33%AUD 0.122026-07-15
3 month+4.76%AUD 0.112026-05-13
Year to date-51.11%AUD 0.232025-12-31
1 year-56%AUD 0.252025-08-14
3 year-51.11%AUD 0.232023-08-14
5 year-76.84%AUD 0.482021-08-13
Since inception-38.89%AUD 0.182019-06-06

Beamtree Financials at a Glance

Market Cap

A$32.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$57.78M

Net Income (TTM)

-A$11.23M

EPS (TTM)

-A$0.02

P/E Ratio

-5.53

Dividend

A$0.00

Beta (Volatility)

0.16 (Low)

Price

A$0.11

Volume

47,280

Open

A$0.11

Previous Close

A$0.11

Daily Range

A$0.11 - A$0.11

52-Week Range

A$0.08 - A$0.30

Estimated Earnings Date

Aug 26, 2026

BMT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Beamtree

Beamtree Holdings Limited, headquartered in Redfern, Australia, specializes in developing and marketing advanced clinical decision support solutions for the healthcare sector. Founded in 1996, the company aims to enhance operational accuracy and patient outcomes through its innovative products and services.

Products and Services
  • RippleDown Expert for live patient monitoring and notifications
  • RippleDown Auditor for automated real-time data verification
  • Q Coding Platform for comprehensive clinical coding and auditing
Growth Outlook
  • Recent quarterly revenue reached AUD 14.53 million, showing consistent demand
  • Expansion into global markets enhances growth potential
  • Investment in R&D aims to innovate and improve product offerings
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 54.5 million reflects steady performance
  • Net income for the latest quarter was AUD -2.87 million, indicating ongoing investment
  • Current ratio of 0.94 suggests adequate short-term financial health
Beamtree Holdings Limited operates in the healthcare information services industry, focusing on clinical decision support systems. The company's diverse product range, including RippleDown Expert and RippleDown Auditor, addresses critical needs in patient monitoring and data verification. The recent quarterly revenue indicates a solid market presence, while ongoing investments in research and development signal a commitment to innovation. Despite facing net income losses, the current ratio reflects a stable financial position, allowing for continued growth and expansion. As the healthcare sector increasingly relies on technology, Beamtree's solutions are well-positioned to meet evolving demands.
AI Generated • Jul 26, 2026

Industry

Health Care Technology

Employees

97

CEO

Marek Stepniak, MBA

Headquarters

North Sydney, NSW 2060, AU

BMT Financials

Key Financial Metrics (TTM)

Gross Margin

5.75%

Operating Margin

-29.95%

Net Income Margin

-20.00%

Return on Equity

-14.19%

Return on Capital

-13.78%

Return on Assets

-10.85%

Earnings Yield

-18.08%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$32.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

292.86M

Volume

47.28K

Avg. Volume

155.04K

Financials (TTM)

Gross Profit

A$6.75M

Operating Income

-A$9.40M

EBITDA

-A$2.82M

Operating Cash Flow

A$2.86M

Capital Expenditure

-A$323.00K

Free Cash Flow

A$2.53M

Cash & ST Invst.

A$2.94M

Total Debt

A$3.65M

Beamtree Performance Analysis

Beamtree annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 16,547,000N/A
20232023-06-30AUD 22,768,00037.6%
20242024-06-30AUD 27,601,00021.2%
20252025-06-30AUD 28,598,0003.6%
Beamtree sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3013.2%
Q22024-12-31-2.9%
Q42025-06-300.9%
Q22025-12-311.2%
Beamtree annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.02N/A
20232023-06-30AUD -0.0351.4%
20242024-06-30AUD -0.02-35.0%
20252025-06-30AUD -0.0217.0%
Beamtree sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3027.6%
Q22024-12-31-47.4%
Q42025-06-309.8%
Q22025-12-312.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$14.53M

+12.2%

Gross Profit

-A$1.05M

+8.8%

Gross Margin

-7.22%

N/A

Market Cap

A$32.22MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$332.11K

N/A

Employees

97

N/A

Net Income

-A$2.87M

+1.2%

EBITDA

-A$467.00K

+34.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$2.94M

-50.0%

Total Debt

A$3.65M

+533.9%

Accounts Receivable

A$7.10M

+16.1%

Inventory

A$0.00

+100.0%

Long Term Debt

A$3.43M

+559.2%

Short Term Debt

A$217.00K

+97.3%

Return on Assets

-10.85%

N/A

Return on Invested Capital

-20.34%

N/A

Free Cash Flow

A$318.00K

+107.4%

Operating Cash Flow

A$436.00K

+118.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EMD.AXEmyria Limited
A$0.05+2.17%
RAD.AXRadiopharm Theranostics Limited
A$0.01-8.33%
DOC.AXDoctor Care Anywhere Group PLC
A$0.11+0.00%
CMP.AXCompumedics Limited
A$0.23+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About BMT

What is the current price of Beamtree?

Beamtree is trading at A$0.11 per share.

What is the 52-week range for Beamtree?

Over the past 52 weeks, Beamtree has traded between A$0.08 and A$0.30.

How much debt does Beamtree have?

As of the most recent reporting period, Beamtree reported total debt of A$3.26M.

How much cash does Beamtree have on hand?

Beamtree reported A$4.78M in cash and cash equivalents in its most recent financial results.

What is Beamtree’s dividend yield?

Beamtree does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.